Compare Arbitrum (ARB) vs Bio Protocol (BIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Arbitrum vs Bio Protocol — how do they compare? Arbitrum trades at Rp1,378 (market cap Rp8,85T, Rp1,07T 24h volume), while Bio Protocol trades at Rp496.87 (market cap Rp1,12T, Rp300,59M 24h volume). The key difference: Arbitrum is far larger — about 7.9× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Arbitrum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 61 Days and Bio Protocol for 16 Days on average.
| ARB | BIO | |
|---|---|---|
Market Cap | Rp8,85T | Rp1,12T |
Volume (24h) | Rp1,07T | Rp300,59M |
Circulating Supply | 6,4B ARB | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 61 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum is trading at Rp1,371 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits below the pivot point of Rp1,402, with immediate support at Rp1,354. Recent ecosystem news includes Pheasant Network's $2 million seed round to advance AI-powered cross-chain technology, potentially benefiting Arbitrum's DeFi ecosystem.
Overall outlook is cautious due to bearish technicals, but network growth and AI integration developments offer long-term opportunities. Key risks include high volatility, regulatory uncertainty, and reliance on Ethereum's ecosystem. Investors should monitor support levels and on-chain activity for signs of trend reversal.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
